Cholangiokines: undervalued modulators in the hepatic microenvironment
Open accessThe DOI matches its Crossref record; 226 of the 229 references it cites were found in a registry or an index.
Abstract
The biliary epithelial cells, also known as cholangiocytes, line the intra- and extrahepatic bile ducts, forming a barrier between intra- and extra-ductal environments. Cholangiocytes are mostly known to modulate bile composition and transportation. In hepatobiliary diseases, bile duct injury leads to drastic alterations in cholangiocyte phenotypes and their release of soluble mediators, which can vary depending on the original insult and cellular states (quiescence, senescence, or proliferation). The cholangiocyte-secreted cytokines (also termed cholangiokines) drive ductular cell proliferation, portal inflammation and fibrosis, and carcinogenesis. Hence, despite the previous consensus that cholangiocytes are bystanders in liver diseases, their diverse secretome plays critical roles in modulating the intrahepatic microenvironment. This review summarizes recent insights into the cholangiokines under both physiological and pathological conditions, especially as they occur during liver injury-regeneration, inflammation, fibrosis and malignant transformation processes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Moreover, their microanatomic niche predisposes BECs to interact with many other cell types, including immune cells, and renders the periductular area a common site of inflammation [155–157].”
From Inflammation and immunity in liver homeostasis and disease: a nexus of hepatocytes, nonparenchymal cells and immune cells (2025) · doi:10.1038/s41423-025-01313-7 · cites this paper as [156]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Biliary epithelial cells (BECs) and their derivatives, often referred to as ductular cells in liver diseases, play a key role in many liver diseases, as the transport of bile to the intestine is a central liver function that needs to be preserved to avoid toxic effects on the liver.”
From Inflammation and immunity in liver homeostasis and disease: a nexus of hepatocytes, nonparenchymal cells and immune cells (2025) · doi:10.1038/s41423-025-01313-7 · cites this paper as [156]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–226 of 226
Regenerative Medicine and the Biliary Tree
De Assuncao, T., Jalan-Sakrikar, N., & Huebert, R. (2017) · Seminars in Liver Disease · doi:10.1055/s-0036-1597818 · Cited by 29
Chusilp, S., Lee, C. M., Li, B., Lee, D., Yamoto, M., Ganji, N., Vejchapipat, P., & Pierro, A. (2020) · Pediatric Surgery International · doi:10.1007/s00383-020-04765-2 · Cited by 28 · cited 2×
“Even though senescent cholangiocytes are not well understood in BA, intrahepatic bile duct-derived organoids exhibited reduced cholangiocyte proliferation after receiving acetaminophen treatment, while enhancing the secretion of TGF-b1 and PDGFBB, which indicated a possible role of senescence in this regard (110).”
BackgroundImmunobiology of the biliary tract system
Björkström, N. K. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2022.08.018 · Cited by 28 · cited 3×
“Investigations of the liver immune landscape revealed that, the recruited leukocytes are the leading responders in the immune response towards bile duct alterations (2, 164).”
BackgroundInfluentialInappropriate diagnosis of necrotizing arachnidism: Watch out Miss Muffet — but don't get paranoid
Kemp, D. R. (1990) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1990.tb125430.x · Cited by 26
Alpini, G. D., Elias, I., Glaser, S. S., Rodgers, R., Phinizy, J. L., Robertson, W. E., Francis, H., Lasater, J., Richards, M., & LeSage, G. (1997) · Journal of Hepatology · doi:10.1016/s0168-8278(97)80184-5 · Cited by 26 · cited 1×
“IFN-g was revealed to ameliorate fibrosis and cholestasis in carbon tetrachloride-treated mice (78).”
BackgroundSeo, D. W., Choi, H., Lee, S. P., & Kuver, R. (2004) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00013.2004 · Cited by 25
Mechanisms of ductular reaction in non-alcoholic steatohepatitis
Chen, Y., Gao, W.-K., Shu, Y.-Y., & Ye, J. (2022) · World Journal of Gastroenterology · doi:10.3748/wjg.v28.i19.2088 · Cited by 25
Povero, D., Tameda, M., Eguchi, A., Ren, W., Kim, J., Myers, R. P., Goodman, Z. D., Harrison, S. A., Sanyal, A. J., Bosch, J., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-06809-0 · Cited by 24
Negative regulation of the hepatic fibrogenic response by suppressor of cytokine signaling 1
Kandhi, R., Bobbala, D., Yeganeh, M., Mayhue, M., Menéndez, A., & Ilangumaran, S. (2015) · Cytokine · doi:10.1016/j.cyto.2015.12.007 · Cited by 23
Zhou, T., Kundu, D., Robles-Linares, J., Meadows, V., Sato, K., Baiocchi, L., Ekser, B., Glaser, S., Alpini, G., Francis, H., et al. (2021) · Cells · doi:10.3390/cells10082072 · Cited by 23
Biliary epithelium: A neuroendocrine compartment in cholestatic liver disease
Ehrlich, L., Scrushy, M., Meng, F., Lairmore, T. C., Alpini, G. D., & Glaser, S. S. (2018) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2018.03.009 · Cited by 22
Zhao, M., Quan, Y., Zeng, J., Lyu, X., Wang, H., Lei, J. H., Feng, Y., Xu, J., Chen, Q., Sun, H., et al. (2021) · International Journal of Biological Sciences · doi:10.7150/ijbs.67379 · Cited by 21
Sakisaka, S., Gondo, K., Yoshitake, M., Harada, M., Sata, M., Kobayashi, K., & Tanikawa, K. (1996) · Hepatology · doi:10.1053/jhep.1996.v24.pm0008690411 · Cited by 19
Shimoyama, S., Kawata, K., Ohta, K., Chida, T., Suzuki, T., Tsuneyama, K., Shimoda, S., Kurono, N., Leung, P. S. C., Gershwin, M. E., et al. (2021) · European Journal of Immunology · doi:10.1002/eji.202048589 · Cited by 19
Sasaki, M., Sato, Y., & Nakanuma, Y. (2021) · Scientific Reports · doi:10.1038/s41598-021-91016-6 · Cited by 19
Morland, C. M., Fear, J., Joplin, R., & Adams, D. (1997) · Biochemical Society Transactions · doi:10.1042/bst025232s · Cited by 19 · cited 1×
“Specifically, IFN-g represses IL-8 secretion while enhancing the secretion of several cytokines including MCP-1 (79), monokine (80), interferon-inducible T cell alpha chemoattractant (ITAC) (81) and interferon-g-inducible protein 10 (IP10) (82).”
BackgroundParticipation of natural killer cells in the pathogenesis of bile duct lesions in biliary atresia
Okamura, A., Harada, K., Nio, M., & Nakanuma, Y. (2012) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2012-201097 · Cited by 18 · cited 1×
“Poly (I:C)-treated primary cholangiocytes, mimicking biliary damage in BA, also trigger a stronger release of chemokine (C-X3-C motif) ligand 1 (CX3CL1) and the subsequent attraction of malfunctional natural killer (NK) cells (74).”
BackgroundMacrophages in cholangiopathies
Bruneau, A., Guillot, A., & Tacke, F. (2022) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000000814 · Cited by 18
Self-citationEthanol-TGFα-MEK Signaling Promotes Growth of Human Hepatocellular Carcinoma
Hennig, M., Yip-Schneider, M., Klein, P. J., Wentz, S. C., Matos, J. M., Doyle, C. J., Choi, J. N., Wu, H., O'Mara, A., Menze, A., et al. (2008) · Journal of Surgical Research · doi:10.1016/j.jss.2008.11.836 · Cited by 16
Yao, Y., Eshun, J. K., Lu, S., Berschneider, H. M., & Black, D. D. (2002) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00397.2001 · Cited by 14 · cited 1×
“Other than inducing biliary bicarbonate secretion by binding with its basolateral receptor (SR) (7, 37, 38), the Sct/SR axis plays a key role in the modulation of biliary proliferation and hepatic fibrosis by influencing the BEC secretome (35, 36, 39).”
BackgroundZaki, N. H. M., Shiota, J., Calder, A. N., Keeley, T. M., Allen, B. L., Nakao, K., Samuelson, L. C., & Razumilava, N. (2022) · Hepatology · doi:10.1002/hep.32492 · Cited by 13
Location, location, location — spatial insight into hepatic macrophage populations
Guillot, A., & Tacke, F. (2022) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-022-00600-2 · Cited by 7
Self-citationFibroblast Growth Factor 19 Induced Changes in Non-malignant Cholangiocytes
Yang, J., Sontag, D., Kung, S., & Minuk, G. Y. (2021) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2021.00087 · Cited by 5 · cited 1×
“Exposure to FGF19 has been associated with the proliferation and IL-6 release of cholangiocytes (42).”
BackgroundYamashita, M., Adachi, T., Ono, S., Yoshino, K., Imamura, H., Matsushima, H., Tanaka, T., Kosaka, T., Soyama, A., Hidaka, M., et al. (2022) · Helicobacter · doi:10.1111/hel.12908 · Cited by 5
Mig chemokine in primary biliary cirrhosis.
Mazzi, V. (2019) · PubMed · doi:10.7417/ct.2019.2135 · Cited by 4 · cited 1×
“Specifically, IFN-g represses IL-8 secretion while enhancing the secretion of several cytokines including MCP-1 (79), monokine (80), interferon-inducible T cell alpha chemoattractant (ITAC) (81) and interferon-g-inducible protein 10 (IP10) (82).”
BackgroundCellular Homeostasis and Repair in the Biliary Tree
Wang, W., Chen, D., Wang, J., & Wen, L. (2022) · Seminars in Liver Disease · doi:10.1055/a-1869-7714 · Cited by 4
Cited by
(2025) · doi:10.1038/s41423-025-01313-7 · Cited by 97
“In reference to “ cholangio-kines ” , the BEC secretome is versatile, and we have just started to explore its potential for shaping portal in fl ammation [156].”
Self-citationCentral role for cholangiocyte pathobiology in cholestatic liver diseases
Jalan-Sakrikar, N., Guicciardi, M. E., O’Hara, S. P., Azad, A., LaRusso, N. F., Gores, G. J., & Huebert, R. C. (2025) · Hepatology · doi:10.1097/hep.0000000000001093 · Cited by 38
The impact of aging on liver health and the development of liver diseases
Williams, S. N., & Ding, W. (2025) · Hepatology Communications · doi:10.1097/hc9.0000000000000808 · Cited by 35
“[29] As the name implies, LSECs are specialized cells that line the hepatic sinusoids and are fenestrated to allow for blood filtration.”
Xiao, M.-H., Wu, S., Liang, P., Ma, D., Zhang, J., Chen, H., Zhong, Z., Liu, J., Jiang, H., Feng, X., et al. (2024) · EBioMedicine · doi:10.1016/j.ebiom.2024.105138 · Cited by 28
Microenvironmental control of the ductular reaction: balancing repair and disease progression
Sorrentino, G. (2025) · Cell Death and Disease · doi:10.1038/s41419-025-07590-4 · Cited by 28
“Cholangio-kines secretion is in fl uenced by different factors such as tissue in fl ammation, infection, and metabolic dysregulation and actively maintain the portal area ’ s microenvironment contributing to immune response and in fl ammation [81].”
Metadata
- Authors
- Cai, X., Tacke, F., Guillot, A., & Liu, H.
- Affiliations
- Charité – Universitätsmedizin Berlin (DE)
- Stiftung Charité (DE)
- Changzhou No.2 People's Hospital (CN)
- Corresponding author
- Guillot, Adrien
- Liu, Hanyang
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2023-05-16
- Volume
- 14
- Pages
- 1192840-1192840
- ISSN
- 1664-3224 (ISSN-L)
- PMC
- PMC10229055
- OpenAlex
- W4376954999
- Cited by
- 40
- References
- 229
- Citations by year
- 2026: 9 · 2025: 21 · 2024: 8 · 2023: 2
- FWCI
- 1.73
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Frontiers in Immunology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Deutsche Forschungsgemeinschaft (DFG SFB/TRR 296, CRC1382, 403224013)
- Deutsche Gesellschaft für Erziehungswissenschaft (BMBF DEEP-HCC consortium)
- Changzhou Science and Technology Bureau (CJ20220142)
- Topics
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Health Sciences › Medicine › Surgery › Cholangiocarcinoma and Gallbladder Cancer Studies
- Keywords
- cholangiocytes, cytokines, bile duct injury, liver fibrosis, ductular reaction, liver regeneration, liver inflammation, hepatocarcinogenesis, cellular senescence, biliary tract
- MeSH terms
- Bile Ducts, Epithelial Cells, Fibrosis, Humans, Inflammation, Liver
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.